Get Live Data
Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. Aptamer Group Share Price
  4. Aptamer Group Share Regulatory News

Pin to quick picksAptamer Group Regulatory News (APTA)

Aptamer Group Information

Share Price Information for Aptamer Group (APTA)

Share Price is delayed by 15 minutes
Get Live Data
0.525    -0.025 (-4.55%)
Bid:
0.50
Ask:
0.55
Spread: 0.05 (10.00%)
Market Cap: £18.14m
APTA Live PriceLast checked at - London Stock Exchange

Intraday Aptamer Group Share Chart

1234
Date   Source Headline
13th Apr 20261:08 pmRNSResult of General Meeting
31st Mar 20267:00 amRNSResult of Retail Offer and Posting of Notice of GM
26th Mar 20267:05 amRNSRetail Offer to raise up to £0.5 million
26th Mar 20267:00 amRNSResults of Placing
25th Mar 20267:10 amRNSInterim Results and Notice of Investor Webinar
25th Mar 20267:00 amRNSProposed Placing, Subscription and Retail Offer
18th Mar 20267:00 amRNSLaunch of targeted radiopharmaceutical programme
10th Mar 20263:26 pmRNSBlock Listing Interim Review
17th Feb 20267:00 amRNS-RTechnical Feasibility for Pathogen Detector
11th Feb 20267:00 amRNSOptimer® Technology in Launched Library Prep Kit
29th Jan 20267:00 amRNSContract wins and first cash licensing receipts
7th Jan 20264:04 pmRNSTrading update - Media comment and speculation
7th Jan 20267:00 amRNSHalf Year Trading Update
23rd Dec 20257:00 amRNSAptamer signs licensing agreement with Alphazyme
23rd Dec 20257:00 amRNSAptamer signs licensing agreement with Alphazyme
16th Dec 202510:34 amRNSLicensing agreement with Twist Bioscience
27th Nov 20251:01 pmRNSResults of 2025 Annual General Meeting
27th Nov 20257:00 amRNSAGM Statement
14th Nov 20257:00 amRNSStrong contract wins build commercial momentum
4th Nov 20257:00 amRNSNew contract with top five pharma company
3rd Nov 20257:00 amRNSPosting of Annual Report and Notice of AGM
14th Oct 20257:00 amRNSFull Year Results for the 12mths to 30 June 2025
13th Oct 20257:00 amRNSNew contract with top 10 pharma
10th Oct 20257:00 amRNSNotice of Results, Analyst & Investor Presentation
8th Oct 20257:00 amRNSMajor top 3 global pharma contract win
26th Sep 20257:00 amRNS-RInvestor Event and Presentation
11th Sep 20257:00 amRNS-RNew contract with Metir plc
9th Sep 20257:00 amRNSNotification of dealings by a director/PDMR
2nd Sep 20257:00 amRNSTherapeutic development agreement with Invizius
28th Aug 20257:00 amRNSBlock Listing Interim Review
27th Aug 20257:00 amRNSBiomarker Discovery Service Launch
22nd Aug 20257:00 amRNSUpdate on licensing and development progress
19th Aug 20257:00 amRNSExercise of warrants
18th Aug 20253:44 pmRNSHolding(s) in Company
18th Aug 20257:00 amRNSContract extension with global pharma partner
8th Aug 20257:00 amRNS-RInvestor Technical Webinar
7th Aug 20255:24 pmRNSHolding(s) in Company
5th Aug 20258:05 amRNSHolding(s) in Company
31st Jul 20251:29 pmRNS-RInvestor Webinar
31st Jul 20257:00 amRNSTrading Update
28th Jul 202512:25 pmRNSHolding(s) in Company
24th Jul 202511:48 amRNSResult of General Meeting
21st Jul 20257:00 amRNSAdditional work commissioned by Unilever
18th Jul 20257:00 amRNSIssue of Equity in lieu of Non-Exec Director Fees
9th Jul 20252:53 pmRNSHolding(s) in Company
8th Jul 20257:00 amRNSPosting of Circular and Notice of General Meeting
4th Jul 20257:00 amRNSPlacing to raise £2.0 million
30th Jun 20257:00 amRNSLiver fibrosis breakthrough with Optimer® platform
25th Jun 20257:00 amRNSAgreement with global life sciences leader
30th May 20257:00 amRNSUnilever second Optimer development programme
1234

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
TEP
Telecom Plus
LSE
0.93%
CAF
CAF.L
LSE
0.00%
APTD
Aptitude
LSE
0.00%
ASDA
ASDA.L
LSE
0.00%
LEAL
LEAL.L
LSE
0.00%
Trending
HE1
Helium One
LSE
6.28%
MAC
Marechale Cap.
LSE
32.88%
IMM
Immupharma
LSE
-5.22%
NEO
Neo Energy Metals
LSE
-10.11%
BSFA
Bio-Sustainable Future Enterprises
LSE
0.00%